Andrea Gallina

Andrea Gallina

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 284 publications

Reply to Kelly M. de Ligt, Sarah P. Psutka, and Laura S. Mertens's Letter to the Editor Re: Martino Pedrani, Alberto De Giorgi, Andrea Gallina, et al. When Patients Refuse Radical Cystectomy: Integrating Trimodality Therapy in the Perioperative ICI/ADC Era. Eur Urol Oncol. 2026;9:743-745. http://dx.doi.org/10.1016/j.euo.2026.04.008.

Reply to Kelly M. de Ligt, Sarah P. Psutka, and Laura S. Mertens's Letter to the Editor Re: Martino Pedrani, Alberto De Giorgi, Andrea Gallina, et al. When Patients Refuse Radical Cystectomy: Integrating Trimodality Therapy in the Perioperative ICI/ADC Era. Eur Urol Oncol. 2026;9:743-745. http://dx.doi.org/10.1016/j.euo.2026.04.008.

Journal: European urology oncology

Published: June 30, 2026

Reply to Kelly M. de Ligt, Sarah P. Psutka, and Laura S. Mertens's Letter to the Editor Re: Martino Pedrani, Alberto De Giorgi, Andrea Gallina, et al. When Patients Refuse Radical Cystectomy: Integrating Trimodality Therapy in the Perioperative ICI/ADC Era. Eur Urol Oncol. In press. http://dx.doi.org/10.1016/j.euo.2026.04.008.

Reply to Kelly M. de Ligt, Sarah P. Psutka, and Laura S. Mertens's Letter to the Editor Re: Martino Pedrani, Alberto De Giorgi, Andrea Gallina, et al. When Patients Refuse Radical Cystectomy: Integrating Trimodality Therapy in the Perioperative ICI/ADC Era. Eur Urol Oncol. In press. http://dx.doi.org/10.1016/j.euo.2026.04.008.

Journal: European urology oncology

Published: June 30, 2026

When Patients Refuse Radical Cystectomy: Integrating Trimodality Therapy in the Perioperative ICI/ADC Era.

When Patients Refuse Radical Cystectomy: Integrating Trimodality Therapy in the Perioperative ICI/ADC Era.

Journal: European urology oncology

Published: April 02, 2026

Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics.

Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics.

Journal: European urology

Published: March 23, 2026

The Diagnostic Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Patients with Rising PSA After Radical Prostatectomy and Postoperative Radiotherapy: A Systematic Review and Meta-analysis.

The Diagnostic Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Patients with Rising PSA After Radical Prostatectomy and Postoperative Radiotherapy: A Systematic Review and Meta-analysis.

Journal: European urology oncology

Published: February 20, 2026

Addressing Uneven Treatment Discontinuation Rate in the Chemotherapy Arm of the EV-302 Phase 3 Randomized Clinical Trial: Implications for Outcome Interpretation.

Addressing Uneven Treatment Discontinuation Rate in the Chemotherapy Arm of the EV-302 Phase 3 Randomized Clinical Trial: Implications for Outcome Interpretation.

Journal: Clinical genitourinary cancer

Published: August 01, 2025

Case Report: Could genetic factors influence the outcomes of first-line enfortumab vedotin plus pembrolizumab therapy in patients with metastatic urothelial carcinoma? Two cases of patients harbouring a BRCA mutation.

Case Report: Could genetic factors influence the outcomes of first-line enfortumab vedotin plus pembrolizumab therapy in patients with metastatic urothelial carcinoma? Two cases of patients harbouring a BRCA mutation.

Journal: Frontiers in oncology

Published: June 16, 2025

Ho: YAG and thulium fiber lasers exhibit comparable temperature distribution: an in vitro evaluation of thermal safety distances for endourological applications-section of EAU endourology.

Ho: YAG and thulium fiber lasers exhibit comparable temperature distribution: an in vitro evaluation of thermal safety distances for endourological applications-section of EAU endourology.

Journal: World journal of urology

Published: April 29, 2025

Trimodal treatment vs radical cystectomy for muscle-invasive bladder cancer: The neglected impact of informative censoring. A systematic review and meta-analysis.

Trimodal treatment vs radical cystectomy for muscle-invasive bladder cancer: The neglected impact of informative censoring. A systematic review and meta-analysis.

Journal: Critical reviews in oncology/hematology

Published: March 31, 2025

Interdisciplinary Swiss consensus recommendations for follow-up after radical cystectomy and trimodal treatment for muscle-invasive bladder cancer.

Interdisciplinary Swiss consensus recommendations for follow-up after radical cystectomy and trimodal treatment for muscle-invasive bladder cancer.

Journal: Bladder cancer (Amsterdam, Netherlands)

Published: March 30, 2025

Robot-Assisted Radical Cystectomy with Ureterocutaneostomy: A Potentially Optimal Solution for Octogenarian and Frail Patients with Bladder Cancer.

Robot-Assisted Radical Cystectomy with Ureterocutaneostomy: A Potentially Optimal Solution for Octogenarian and Frail Patients with Bladder Cancer.

Journal: Journal of clinical medicine

Published: March 22, 2025

Expanding the clinical spectrum of PPP3CA variants - alternative isoforms matter.

Expanding the clinical spectrum of PPP3CA variants - alternative isoforms matter.

Journal: Orphanet journal of rare diseases

Published: November 15, 2024

Showing 1-12 of 284

Last Updated: 09/26/2026